These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19911066)

  • 1. In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.
    Chachanidze V; Curbelo-Irizarry A; Ashcraft D; Pankey G
    Interdiscip Perspect Infect Dis; 2009; 2009():984934. PubMed ID: 19911066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.
    Rizvi M; Ahmad J; Khan F; Shukla I; Malik A; Sami H
    Australas Med J; 2015; 8(1):1-6. PubMed ID: 25848402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
    Burgess DS; Nathisuwan S
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):35-41. PubMed ID: 12376029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
    Pankey GA; Ashcraft DS
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.
    Shortridge D; Pfaller MA; Streit JM; Flamm RK
    J Glob Antimicrob Resist; 2020 Jun; 21():60-64. PubMed ID: 31648032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
    Drago L; De Vecchi E; Nicola L; Colombo A; Guerra A; Gismondo MR
    Chemotherapy; 2004 Oct; 50(4):202-10. PubMed ID: 15452399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of
    García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis.
    Lasko MJ; Huse HK; Nicolau DP; Kuti JL
    Ann Clin Microbiol Antimicrob; 2021 Jan; 20(1):9. PubMed ID: 33468149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Burgess DS; Hastings RW
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):37-41. PubMed ID: 11025182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
    Vidaillac C; Leonard SN; Sader HS; Jones RN; Rybak MJ
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2360-6. PubMed ID: 19349512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa.
    Cuba GT; Rocha-Santos G; Cayô R; Streling AP; Nodari CS; Gales AC; Pignatari ACC; Nicolau DP; Kiffer CRV
    J Antimicrob Chemother; 2020 Jul; 75(7):1874-1878. PubMed ID: 32240299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method.
    He W; Kaniga K; Lynch AS; Flamm RK; Davies TA
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):417-9. PubMed ID: 22995366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.
    Dundar D; Otkun M
    Yonsei Med J; 2010 Jan; 51(1):111-6. PubMed ID: 20046523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
    Dawis MA; Isenberg HD; France KA; Jenkins SG
    J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ceftolozane-tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata - SMART United States 2016-2017.
    Lob SH; Hoban DJ; Young K; Motyl MR; Sahm DF
    J Glob Antimicrob Resist; 2020 Mar; 20():209-213. PubMed ID: 31351246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of combination therapy by time kill curve analysis and chequerboard assay for treatment of multi-drug resistant Pseudomonas aeruginosa isolates.
    Rizvi M; Ahmed J; Khan F; Shukla I; Malik A
    J Glob Antimicrob Resist; 2013 Jun; 1(2):103-108. PubMed ID: 27873576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
    Adams EK; Ashcraft DS; Pankey GA
    Am J Med Sci; 2016 Mar; 351(3):265-70. PubMed ID: 26992255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa.
    Piccoli L; Guerrini M; Felici A; Marchetti F
    J Chemother; 2005 Aug; 17(4):355-60. PubMed ID: 16167512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa.
    Bailey AL; Armstrong T; Dwivedi HP; Denys GA; Hindler J; Campeau S; Traczewski M; Humphries R; Burnham CA
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.